InsiderTrades

Form 4 for BIO BIO-RAD LABORATORIES, INC.

Accepted 2022-09-06 00:00:00 ET · period of report 2022-09-01 · accession 0001062993-22-019202 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-09-06 2022-09-01 BIO SCHWARTZ NORMAN D COB, Pres, CEO, Dir, 10% F - Tax $486.25 -767 424.2K -0.2% -$373.0K
D 2022-09-06 2022-09-01 BIO SCHWARTZ NORMAN D COB, Pres, CEO, Dir, 10% M - OptEx $0.00 +1,266 424.9K +0.3% $0
D 2022-09-06 2022-09-01 BIO SCHWARTZ NORMAN D COB, Pres, CEO, Dir, 10% M - OptEx $0.00 -1,266 3,798 -25% $0
D 2022-09-06 2022-09-01 BIO SCHWARTZ NORMAN D COB, Pres, CEO, Dir, 10% A - Grant $0.00 +8,326 8,326 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Bio-Rad A Common Stock 2022-09-01 F D 767 $486.25 424,169 D — —
2 Common Bio-Rad A Common Stock 2022-09-01 M A 1,266 $0.00 424,936 D — — (F1) Shares of Class A common stock acquired on the vesting of restricted stock units.
3 Derivative Restricted Stock Units 2022-09-01 M D 1,266 $0.00 3,798 D $0.00 · — to — 1,266 Bio-Rad A Common Stock (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F6) On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
4 Derivative Restricted Stock Units 2022-09-01 A A 8,326 $0.00 8,326 D $0.00 · — to — 8,326 Bio-Rad A Common Stock (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.